| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Experimental Therapeutics and Grace Cancer Drug Center, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263
The selective effects of 24 agents on mouse spleen effector functions involved in the immune responses to sheep erythrocytes have been demonstrated. Five tests were used to assay the effector functions: the complement-dependent cellular cytotoxicity test, which measures complement-mediated lysis in the presence of antibody excreted from B-cell effectors; the complement-in-dependent cellular cytotoxicity test, which measures lysis after non-T-cell, non-B-cell interactions with target cells coated with antibody excreted by B-cells within the same spleen cell populations; the antibody-dependent cellular cytotoxicity test, which measures lysis after non-T-cell, non-B-cell interactions with antiserum-coated target cells; the complement-independent phagocytic test and the antibody-dependent phagocytic test, which measure phagocytosis of target cells coated with endogenous and added antibody, respectively. These five tests were, in general, insensitive to inhibitors of DNA synthesis. Phagocytosis and lysis associated with complement-independent cellular cytotoxicity were selectively sensitive to protein inhibitors, anthracycline antibiotics, bleomycin, actinomycin D, 2-deoxy-D-glucose, and N6-benzyladenosine. All functions, except complement-dependent cellular cytotoxicity, were inhibited by agents that affect cellular motility and/or membrane characteristics. The complement-dependent cellular cytotoxicity was only affected by agents that probably acted in a nonspecific cytotoxic manner. Potentiation of immune function was demonstrated in one case, namely, with N6-(
2-isopentenyl)adenosine. The demonstrated selectivity of action of the agents studied in vitro permitted speculation concerning the cellular effector functions involved in the efferent arm of the mouse spleen cell response to sheep erythrocytes and indicated selectivities on cellular functions that may become relevant in vivo.
1 This investigation was supported in part by USPHS Grants CA-15142 and CA-13038.
2 Present address: S. Farber Cancer Center, Division of Tumor Immunology, Boston, Mass. 02115.
Received 11/23/76. Accepted 11/17/77.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |